hepatitis B core‐related antigen (HB crAg): an emerging marker for chronic hepatitis B virus infection
Summary Background Chronic hepatitis B (CHB) cannot be completely eradicated due to
the presence of covalently closed circular DNA (ccc DNA) in the nuclei of infected …
the presence of covalently closed circular DNA (ccc DNA) in the nuclei of infected …
[HTML][HTML] Novel biomarkers for the management of chronic hepatitis B
T Inoue, Y Tanaka - Clinical and molecular hepatology, 2020 - ncbi.nlm.nih.gov
Hepatitis B virus (HBV) cannot be eliminated completely from infected hepatocytes because
of the presence of intrahepatic covalently closed circular DNA (cccDNA). As chronic hepatitis …
of the presence of intrahepatic covalently closed circular DNA (cccDNA). As chronic hepatitis …
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
P Lampertico, K Agarwal, T Berg, M Buti… - Journal of …, 2017 - Elsevier
Hepatitis B virus (HBV) infection remains a global public health problem with changing
epidemiology due to several factors including vaccination policies and migration. This …
epidemiology due to several factors including vaccination policies and migration. This …
[HTML][HTML] Guidelines for prevention and treatment of chronic hepatitis B
G Wang, Z Duan - Journal of clinical and translational hepatology, 2021 - ncbi.nlm.nih.gov
To achieve the goal of the World Health Organization to eliminate viral hepatitis as a major
public health threat by 2030, the Chinese Society of Infectious Diseases and the Chinese …
public health threat by 2030, the Chinese Society of Infectious Diseases and the Chinese …
Guidelines for the prevention and treatment of chronic hepatitis B (version 2022)
H You, FS Wang, T Li, X Xu, Y Sun, Y Nan… - Infectious Diseases & …, 2023 - mednexus.org
To facilitate the achieving of the goal of" eliminating viral hepatitis as a major public health
threat by 2030" set by the World Health Organization, the Chinese Society of Hepatology …
threat by 2030" set by the World Health Organization, the Chinese Society of Hepatology …
慢性乙型肝炎防治指南(2019 年版).
王贵强， 段钟平 - Journal of Clinical Hepatology/Linchuang …, 2019 - search.ebscohost.com
中华医学会感染病学分会,中华医学会肝病学分会 Page 1 +,-. 慢性乙型肝炎防治指南(2019 年版
) 中华医学会感染病学分会,中华医学会肝病学分会 摘要:为了实现世界卫生组织提出的“2030 年 …
) 中华医学会感染病学分会,中华医学会肝病学分会 摘要:为了实现世界卫生组织提出的“2030 年 …
Clinical efficacy of a novel, high-sensitivity HBcrAg assay in the management of chronic hepatitis B and HBV reactivation
T Inoue, S Kusumoto, E Iio, S Ogawa, T Suzuki… - Journal of …, 2021 - Elsevier
Background & Aims A fully automated, novel high-sensitivity hepatitis B core-related antigen
assay (iTACT-HBcrAg) has been developed. We demonstrate the clinical utility of iTACT …
assay (iTACT-HBcrAg) has been developed. We demonstrate the clinical utility of iTACT …
[HTML][HTML] Interferon and hepatitis B: current and future perspectives
J Ye, J Chen - Frontiers in Immunology, 2021 - frontiersin.org
Chronic hepatitis B virus (HBV) infection remains a major health burden worldwide for which
there is still no effective curative treatment. Interferon (IFN) consists of a group of cytokines …
there is still no effective curative treatment. Interferon (IFN) consists of a group of cytokines …
[HTML][HTML] Clinical applications of transient elastography
KS Jung, SU Kim - Clinical and molecular hepatology, 2012 - ncbi.nlm.nih.gov
Chronic liver disease represents a major public health problem, accounting for significant
morbidity and mortality worldwide. As prognosis and management depend mainly on the …
morbidity and mortality worldwide. As prognosis and management depend mainly on the …
Interferon treatment for hepatitis B
MA Konerman, AS Lok - Clinics in Liver Disease, 2016 - liver.theclinics.com
Chronic hepatitis B virus (HBV) infection has a significant public health impact with roughly
250 million persons worldwide chronically infected. 1 HBV infection is a major cause of liver …
250 million persons worldwide chronically infected. 1 HBV infection is a major cause of liver …